Yanez, Betina
Taub, Chloe J.
Waltz, Margaret
Diaz, Alma
Buitrago, Diana
Bovbjerg, Katrin
Chicaiza, Anthony
Thompson, Rebecca
Rowley, Scott
Moreira, Jonathan
Graves, Kristi D.
Rini, Christine
Funding for this research was provided by:
National Cancer Institute (R01CA223963-03S1, T32CA193193)
Article History
Accepted: 14 September 2022
First Online: 20 October 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: This article does not contain any studies with animals performed by any of the authors.
: Betina Yanez, Chloe Taub, and Diana Buitrago are consultants for Blue Note Therapeutics. Jonathan Moreira participated on a drug advisory board for CTI BioPharma Corp. All other authors have no declarations of interest.
Free to read: This content has been made available to all.